J. Doyen

Prognostic factors in 1038 women with metastatic breast cancer

R. Largillier, Jean-­Marc Ferrero, J. Doyen et al. · Annals of Oncology · 2008 · 380 citations · Full text

Medicine, Biostatistics, Oncology +14

MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines

Sébastien Grosso, J. Doyen, Scott K. Parks et al. · Cell Death and Disease · 2013 · 213 citations · Full text

Medicine, Cancer Biology, Oncology +17

Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome

J. Doyen, C. Trastour, F. Ettore et al. · Biochemical and Biophysical Research Communications · 2014 · 114 citations · Full text

Medicine, Cancer Biology, Oncology +14

A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy

Carine El Sissy, Amos Kirilovsky, Marc Van den Eynde et al. · Clinical Cancer Research · 2020 · 108 citations · Full text

Medicine, Oncology, Pathology +17

Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer

D. Azria, J. Doyen, Marta Jarlier et al. · Annals of Oncology · 2017 · 106 citations · Full text

Medicine, Oncology, Radiation Oncology +15